Advertisement

Topics

AbbVie brain cancer drug fails late-stage study in another oncology setback

05:20 EDT 17 May 2019 | BioPharmaDive

An interim review found the glioblastoma drug didn't improve survival, leading the biotech to end the trial early and halt enrollment for other studies.

Original Article: AbbVie brain cancer drug fails late-stage study in another oncology setback

NEXT ARTICLE

More From BioPortfolio on "AbbVie brain cancer drug fails late-stage study in another oncology setback"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...